Empresa Phoenix Life Sciences International Limited Other OTC
Acciones
PLSI
US71910Q1022
Farmacéuticos
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Lewis Humer
CHM | Chairman | 65 | 25/04/14 |
Stephen Cornford
CIO | Chief Investment Officer | - | - |
David Steinman
LAW | General Counsel | - | 01/02/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Lewis Humer
CHM | Chairman | 65 | 25/04/14 |
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 10 084 582 | 8 644 192 ( 85,72 %) | 0 | 85,72 % |
Información de la empresa
Phoenix Life Sciences International Ltd.
1810 East Sahara Avenue Suite 215
89139, Las Vegas
+
http://www.phoenixlife.coVaria. 1 de ene. | Capi. | |
---|---|---|
+40,73 % | 739 mil M | |
+32,83 % | 598 mil M | |
-6,30 % | 353 mil M | |
+15,15 % | 318 mil M | |
+4,05 % | 285 mil M | |
+15,00 % | 240 mil M | |
-5,52 % | 206 mil M | |
+6,17 % | 164 mil M | |
-0,45 % | 162 mil M |